The HER2-positive breast cancer tumors within the HH group had a tendency toward a higher proportion of HER2 IHC 2+ than 3+ expression, and the HER2 FISH ratio in the HH group was notably expressed higher than that of the LH group (Table 2). The gene discussed is ERBB2; the disease is breast carcinoma.